Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study.
Sengsayadeth S, Labopin M, Boumendil A, Finke J, Ganser A, Stelljes M, Ehninger G, Beelen D, Niederwieser D, Blaise D, Dreger P, Mufti G, Chevallier P, Mailhol A, Gatwood KS, Gorin N, Esteve J, Ciceri F, Baron F, Schmid C, Giebel S, Mohty M, Savani BN, Nagler A. Sengsayadeth S, et al. Among authors: gatwood ks. Biol Blood Marrow Transplant. 2018 Jul;24(7):1406-1414. doi: 10.1016/j.bbmt.2018.04.008. Epub 2018 Apr 17. Biol Blood Marrow Transplant. 2018. PMID: 29678639 Free article.
Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia.
Gatwood KS, Culos KA, Binari LA, Engelhardt BG, Kassim A, Byrne MT, Goodman SA, Chinratanalab W, Sengsayadeth SM, Greer JP, Jagasia M, Savani BN. Gatwood KS, et al. Bone Marrow Transplant. 2018 Jun;53(6):795-799. doi: 10.1038/s41409-018-0124-6. Epub 2018 Mar 14. Bone Marrow Transplant. 2018. PMID: 29540851 No abstract available.
Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program.
McDonald MK, Culos KA, Gatwood KS, Prow C, Chen H, Savani BN, Byrne M, Kassim AA, Engelhardt BG, Jagasia M, Satyanarayana G. McDonald MK, et al. Among authors: gatwood ks. Biol Blood Marrow Transplant. 2018 Oct;24(10):2081-2087. doi: 10.1016/j.bbmt.2018.04.031. Epub 2018 May 9. Biol Blood Marrow Transplant. 2018. PMID: 29753159 Free article.
Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study.
Sengsayadeth S, Gatwood KS, Boumendil A, Labopin M, Finke J, Ganser A, Stelljes M, Ehninger G, Beelen D, Niederwieser D, Blaise D, Dreger P, Mufti G, Chevallier P, Mailhol A, Gilleece MH, Gorin N, Esteve J, Ciceri F, Baron F, Schmid C, Giebel S, Mohty M, Savani BN, Nagler A. Sengsayadeth S, et al. Among authors: gatwood ks. Blood Adv. 2018 Aug 28;2(16):2127-2135. doi: 10.1182/bloodadvances.2018019976. Blood Adv. 2018. PMID: 30143527 Free PMC article. Clinical Trial.
American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Survey on Chimeric Antigen Receptor T Cell Therapy Administrative, Logistic, and Toxicity Management Practices in the United States.
Mahmoudjafari Z, Hawks KG, Hsieh AA, Plesca D, Gatwood KS, Culos KA. Mahmoudjafari Z, et al. Among authors: gatwood ks. Biol Blood Marrow Transplant. 2019 Jan;25(1):26-33. doi: 10.1016/j.bbmt.2018.09.024. Epub 2018 Sep 26. Biol Blood Marrow Transplant. 2019. PMID: 30266675 Free article.
Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post-transplant cytoxan for sickle cell disease.
Patel DA, Dhedin N, Chen H, Karnik L, Gatwood K, Culos K, Mohan S, Engelhardt BG, Kitko C, Connelly J, Satyanarayana G, Jagasia M, De La Fuente J, Kassim A. Patel DA, et al. Transpl Infect Dis. 2020 Feb;22(1):e13222. doi: 10.1111/tid.13222. Epub 2019 Dec 19. Transpl Infect Dis. 2020. PMID: 31782875 Free PMC article.
Risk factors associated with early viral reactivation following haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: a pilot study.
Baskett J, Culos KA, Satyanarayana G, Patel D, Engelhardt B, Savani B, Jagasia M, Kassim AA, Gatwood KS. Baskett J, et al. Among authors: gatwood ks. Ann Hematol. 2020 May;99(5):1137-1139. doi: 10.1007/s00277-020-03972-0. Epub 2020 Mar 6. Ann Hematol. 2020. PMID: 32140894 No abstract available.
The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia.
Byrne M, Danielson N, Sengsayadeth S, Rasche A, Culos K, Gatwood K, Wyatt H, Chinratanalab W, Dholaria B, Ferrell PB, Fogo K, Goodman S, Jagasia M, Jayani R, Kassim A, Mohan SR, Savani BN, Strickland SA, Engelhardt BG, Savona M. Byrne M, et al. Am J Hematol. 2020 Sep;95(9):1006-1014. doi: 10.1002/ajh.25859. Epub 2020 Jun 15. Am J Hematol. 2020. PMID: 32390196 Free article. Clinical Trial.
24 results